The Chemours Company (CC) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary reflects a negative sentiment due to several factors: expected sequential declines in net sales across segments, muted market conditions, and significant cost impacts. Despite some positive elements like Opteon growth and cost-out efforts, the overall guidance indicates a challenging environment. The Q&A session highlighted concerns about inventory levels, market weakness, and unclear management responses regarding capacity rationalizations and market share gains. Given the company's mid-cap size, these challenges are likely to result in a negative stock price movement in the short term.
Key Financial Performance
Net Proceeds from Kuan Yin Site Sale $300 million expected, aimed at reducing outstanding debt and lowering targeted net leverage below 3x.
Free Cash Flow (Q4 2025) $92 million, reflecting Chemours' longer-term cash generation potential.
TSS Opteon Sales Growth (Q4 2025) 37% year-over-year growth, driven by higher pricing, moderate volume increases, and favorable mix for Opteon Refrigerant blends.
Annual Opteon Refrigerant Growth (2025) 56%, making up 75% of total refrigerant sales, up from 56% the year before.
TSS Adjusted EBITDA Margins (2025) 32%, up from 31% in the prior year, despite $22 million in R&D investment for liquid cooling and next-generation refrigerants.
TT Adjusted EBITDA (Q4 2025) Ahead of expectations due to stabilized pricing and cost performance, despite tepid global market conditions.
APM Free Cash Flow (Q4 2025) Strengthened despite headwinds in auto and industrial construction markets.
Corporate Expenses (Q4 2025) Significant decrease compared to the same quarter last year, reflecting expense management efforts.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Opteon Refrigerants: Achieved record sales with 37% growth in Q4 2025 compared to the prior year. Annual growth of 56%, making up 75% of total refrigerant sales in 2025. Growth driven by U.S. AIM Act and strong adoption.
Liquid Cooling Solutions: Progress in commercializing 2-phase liquid cooling solutions, including qualification by Samsung Electronics and a manufacturing agreement with Navin Fluorine. Targeting initial production in Q3 2026.
Market Expansion in Data Centers and Semiconductors: Sustained growth in high-value data center and semiconductor markets, with strong order book for APM's Performance Solutions products.
Cost Savings: Achieved $125 million in gross controllable cost savings in 2025. Continued focus on operational excellence and cost reduction.
Mining Operations Restructuring: Idled one mine in North Florida and transitioned to a third-party contractor to improve cost efficiency and cash generation.
Washington Works Facility: Temporary shutdown due to equipment issues and weather delays. Operations resumed, with plans for long-term reliability improvements.
Kuan Yin Site Sale: Sale of the site for $300 million to reduce debt and improve leverage ratio.
Portfolio Management: Closure of Villers-Saint-Paul site in France and restructuring of European assets to align with market demand.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Titanium Dioxide Operations Shutdown: The shutdown of the titanium dioxide operations at the Kuan Yin site in 2023 and subsequent decommissioning efforts could pose challenges in terms of operational adjustments and financial impacts.
APM Business Market Weakness: The APM business faced near-term end market weakness, particularly in auto and industrial construction sectors, which could impact financial performance.
Washington Works Facility Outage: A disruption at the Washington Works facility due to a local utility service outage caused a temporary shutdown, limiting capacity and resulting in delays to restart operations.
Mining Operations Restructuring: The restructuring of mining operations, including the temporary idling of a mine in North Florida and transitioning to a third-party contractor, may lead to operational and cost challenges.
TT Business Seasonal Volume Decline: The TT business is experiencing weaker seasonal volumes in non-Western markets, which could impact sales and financial performance.
APM Business Facility Closure: The closure of the Advanced Materials SPS Capstone line in 2025 could result in lower net sales, requiring replacement with higher-margin products.
Regulatory and Market Demand Risks: The reliance on regulatory-driven market demand, such as the U.S. AIM Act, for Opteon Refrigerants could pose risks if regulatory or market conditions change.
Raw Material Cost Increases: Increased raw material costs, particularly for R32 used in stationary refrigerants, could impact profitability.
European Asset Review: The ongoing European asset review, extending into 2027, may create uncertainty and potential operational disruptions.
Legacy Liabilities: The company faces legacy liabilities, including a proposed judicial consent order with the state of New Jersey, which could have financial and reputational implications.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue and Sales Projections: For the first quarter of 2026, TSS net sales are projected to rise sequentially by 20%-30%, driven by seasonal trends and growth in Opteon Refrigerants. Full-year 2026 consolidated net sales growth is expected to be between 3%-5%.
Adjusted EBITDA: TSS adjusted EBITDA for Q1 2026 is anticipated to range from $170 million to $185 million. Full-year 2026 adjusted EBITDA is projected to range from $800 million to $900 million.
Capital Expenditures: Capital expenditures for Q1 2026 are expected to be $50 million, with full-year 2026 expenditures ranging from $275 million to $325 million.
Free Cash Flow: Free cash flow conversion for 2026 is expected to exceed 25%, supported by improved earnings and working capital improvements.
Debt Reduction: Proceeds from the Kuan Yin site sale ($300 million) will be used to reduce debt, targeting a net leverage ratio below 4x adjusted EBITDA by the end of 2026, with a long-term goal of below 3x.
TSS Segment Growth: Double-digit growth in Opteon Refrigerants is expected to continue into Q2 2026, normalizing in the second half of the year. Benefits from cost-out efforts and capacity expansion at Corpus Christi will support strong sales and earnings growth.
TT Segment Outlook: TT net sales are expected to decrease slightly in Q1 2026 due to seasonal volume declines in non-Western markets. However, pricing trends and cost-saving initiatives are expected to drive improved earnings and cash flow throughout 2026.
APM Segment Outlook: APM net sales are projected to decrease in Q1 2026 due to market weakness and the Washington Works outage. However, demand in semiconductor and data center markets is expected to drive improved sales and earnings for the remainder of 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Could you share some more detail on the assumptions for TiO2 volume growth that are embedded in your 2026 guidance? What do you expect the global industry to grow volumes at this year? And how would you expect your volume growth to compare to the industry average?
A:The outlook is that demand is stable with no major demand triggers. The company announced a price increase in December and has seen strong yield from it. Pricing is expected to remain flat year-over-year into Q1, with stabilized demand and pricing power.
Q:Do you have a lot of sight for meaningful progress towards resolving your legacy liabilities during 2026? Any key items or dates to watch out for this year?
A:Significant progress has been made, particularly in New Jersey, which laid a framework for future progress. Focus areas include facilities in West Virginia and North Carolina, with additional updates expected throughout the year.
Q:Could you peel apart some of the different end markets in the APM segment to let us know how much some are down and where some of the strength is?
A:Auto and industrial production are down, but there is strong demand in the Performance Solutions portfolio, particularly in Teflon products related to AI, data center build-outs, semiconductors, and memory chips.
Q:Why not pull all of the 2027 maintenance until whatever downtime you've got here in the March quarter of 2026?
A:Regular turnarounds occur every three years, and maintenance planned for early next year has already been pulled forward due to disruptions in January. The focus is on ensuring reliable operations and stable performance, with the current turnaround being more of a tune-up than significant maintenance.
Q:Could you talk about the Q1 and full-year guidance, including the bridge items as you move into Q2?
A:The Q1 midpoint is $135 million, and the full-year midpoint is $850 million. Q2 is expected to benefit from seasonality, strength in refrigerants and Opteon, and pricing momentum. Unusual items in Q1 include a $20-$25 million impact from the Washington Works outage and $17 million from inventory and ore mix issues.
Q:Could you walk us through the free cash flow expectations for the year?
A:The company expects free cash flow to exceed 25% for the year. Q1 will see a working capital outflow of over $100 million due to seasonality, but the full-year cash generation capabilities are strong, with a focus on unlocking working capital and driving earnings.
Q:Can you walk through the anti-dumping activities in India, Brazil, and Europe? What have you seen in those areas, and what do you think is still left?
A:Anti-dumping duties have been beneficial. Brazil has high duties and a strong market, India is expected to reinstate duties after some back-and-forth, and Europe has seen uplift despite currency changes benefiting Chinese producers.
Q:What impact has the bringing online of Corpus Christi had, and what benefits are left as the plant fully ramps up?
A:Corpus Christi is in a two-year ramp-up phase. Improvements in margin from cost reductions and pricing were seen last year, with further benefits expected this year. The technology is the lowest-cost globally, providing strong tailwinds.
Q:Should we model the ore mix impact in TT continuing, or is it contained in Q1?
A:The Q1 ore mix impact was due to winter interruptions requiring higher-grade ore. One unfavorable long-term contract has ended, and the second is being worked through. Restructuring efforts aim to lower input costs and improve competitiveness.
Q:What do you expect on the Freon side of the business?
A:Freon saw tailwinds in Q4, and pricing momentum is expected to continue into 2026. Execution on both Opteon and Freon sides has been strong, with growth anticipated next year.
Q:What is baked into the $800-$900 million EBITDA guidance for TT in terms of anti-dumping-related market share gains?
A:The focus is on executing a global price increase rather than volume growth. The market is projected to remain stable, with no significant growth expected. Duties have been helpful but are not the primary focus.
Q:Are you still comfortable with the 1.1 million tonnes of capacity rationalizations since 2023? What about potential rationalizations in China?
A:The company is confident in the 1.1 million tonnes of announced capacity rationalizations. No additional rationalizations in China have been observed yet.
Q:What would get you to the high or low end of your full-year range?
A:The high end depends on market evolution, cost reductions, and pricing execution. The low end could result from unexpected cost increases, less price receptivity, or volume depression.
Q:How do you see the growth algorithm for TSS playing out, especially relative to mid- to high single-digit sales growth over the longer term?
A:Significant growth is expected from the HFO transition, residential segment recovery, and opportunities in data centers and chillers. The company remains aligned with its long-term growth targets.
Q:What are your residential HVAC customers doing, and how does that impact your mix?
A:Customers reduced inventory in Q4, but replenishment is expected in the first half of the year. Growth is anticipated in the residential segment, aftermarket, and data centers, with double-digit growth expected in the first half.
Q:What is inhibiting you from achieving higher than 25% free cash flow conversion in 2026?
A:Inventory levels are higher than needed, partly due to take-or-pay contracts for high-grade ore. Efforts are underway to reduce inventory and improve cash conversion. CapEx will increase due to planned maintenance activities.
Q:What happened in Asia with TT revenues, and where is that business going?
A:Revenues in Asia declined due to a focus on fair trade markets and temporary pullbacks on tariffs in India. The company is confident in the eventual reinstatement of duties.
Q:Why have inventories grown significantly since 2019, and what can be done about it?
A:Inventory growth is partly due to changes in the business, such as the addition of Corpus Christi, and take-or-pay contracts for high-grade ore. Efforts are being made to normalize inventory levels and improve efficiency.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing potential additional capacity rationalizations in China, stating they had not observed much more beyond the announced 1.1 million tonnes. Additionally, when asked about market share gains from anti-dumping measures, the response focused on pricing execution rather than providing specific details on volume growth or market share expectations.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
APM Solutions
HVAC
Opteon Refrigerant
Refrigerants
Solutions product
TSS line
TSS record
Washington Works
benefit cost
breakeven
cash generation
chemical
decision
demand pricing
digit Opteon
dioxide
effect
effort cash
expectation TSS
expectation pricing
flow generation
generation APM
leverage ratio
line sale
market effort
market pricing
mineral sale
objective
outage
outlook driver
pigment sale
pricing announcement
pricing strength
realization cost
sale TSS
sale facility
term cost
timing
unit
CC Transcript
The Chemours Company (CC) Q1 2026 Earnings Call Transcript
Unknown5-6
The earnings call summary highlights several negative financial indicators, including a 10% decline in revenue, a 15% drop in net income, and a 12% decrease in adjusted EBITDA. Additionally, the free cash flow and gross margin have declined, and forward-looking statements indicate potential risks. The absence of positive strategic initiatives or operational updates further contributes to a negative sentiment. Given the market cap of $3.4 billion, the stock price is likely to experience a negative movement of -2% to -8% over the next two weeks.
The Chemours Company (CC) Q4 2025 Earnings Call Transcript
Unknown2-20
The earnings call summary reflects a negative sentiment due to several factors: expected sequential declines in net sales across segments, muted market conditions, and significant cost impacts. Despite some positive elements like Opteon growth and cost-out efforts, the overall guidance indicates a challenging environment. The Q&A session highlighted concerns about inventory levels, market weakness, and unclear management responses regarding capacity rationalizations and market share gains. Given the company's mid-cap size, these challenges are likely to result in a negative stock price movement in the short term.
The Chemours Company (CC) Q3 2025 Earnings Call Transcript
Unknown11-7
The earnings call summary indicates declining sales and EBITDA across multiple segments, operational disruptions, and financial shortfalls. Although there are some positive aspects like cost reductions and strategic growth plans, the overall sentiment is negative due to weak guidance, operational issues, and market uncertainties. The Q&A section further highlights concerns over demand, tariffs, and inventory issues. Given the company's market cap and the negative aspects outweighing positives, a negative stock price movement is anticipated.
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
Positive8-6
The earnings call summary shows strong financial performance, with significant growth in key segments like TSS and Advanced Materials. The strategic agreement with Navin Fluorine and cost reduction initiatives further enhance the outlook. The Q&A section reveals management's confidence in overcoming operational challenges and achieving long-term growth, despite some uncertainties. The market cap suggests a moderate reaction, leading to a positive forecast of 2% to 8% stock price increase over the next two weeks.
CC Slides
CC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
